Abstract Mammographic density (MD) is the area of breast tissue that appears radiologically white on mammography. Although high MD is a strong risk factor for breast cancer, independent of BRCA1/2 mutation status, the molecular basis of high MD and its associated breast cancer risk is poorly understood. MD studies will benefit from an animal model, where hormonal, gene and drug perturbations on MD can be measured in a preclinical context. High and low MD tissues were selectively sampled by stereotactic biopsy from operative specimens of high-risk women undergoing prophylactic mastectomy. The high and low MD tissues were transferred into separate vascularised biochambers in the groins of SCID mice. Chamber material was harvested after 6 weeks for histological analyses and immunohistochemistry for cytokeratins, vimentin and a human-specific mitochondrial antigen. Within-individual analysis was performed in replicate mice, eliminating confounding by age, body mass index and process-related factors, and comparisons were made to the parental human tissue. Maintenance of differential MD post-propagation was assessed radiographically. Immunohistochemical staining confirmed the preservation of human glandular and stromal components in the murine biochambers, with maintenance of radiographic MD differential. Propagated high MD regions had higher stromal (p = 0.0002) and lower adipose (p = 0.0006) composition, reflecting the findings in the original human breast tissue, although glands appeared small and non-complex in both high and low MD groups. No significant differences were observed in glandular area (p = 0.4) or count (p = 0.4) between high and low MD 
Introduction
Mammographic density (MD) refers to the area of radiologically white tissue on a mammogram [1] ; percentage MD (PMD) is the proportion of MD area on a mammogram. High PMD carries significant clinical importance, as it is the strongest risk factor for breast cancer, after age and BRCA1/ 2 mutation, when adjusted for BMI [2, 3] . The breast cancer risk associated with the highest PMD category is four to six times greater than the lowest category [4] [5] [6] [7] [8] . Reduction in PMD was also a significant indicator of reduction in breast cancer risk in the IBIS-1 prevention trial with Tamoxifen [9] . This provides an impetus for the evaluation of MD as a biomarker for breast cancer risk, and suggests a role for MD in predicting response to Tamoxifen [10] .
The molecular basis of high MD and its associated breast cancer risk is poorly understood. PMD appears to be most influenced by the relative proportions of fat and stroma, where stromal, epithelial cells and collagen may contribute to the radiographic density in mammograms [11, 12] . We previously examined high and low MD material sampled by stereotactic biopsy from within the same breast, finding that high MD areas had increased dense connective tissue and reduced fat, as well as a trend towards smaller epithelial glands, with increased perimeter [13] .
Currently, there are few suitable animal models in which to study MD. While radiological examination of mouse mammary fat pads (MFPs) in vivo and ex vivo has been described [14] , quantification of MFP radiographic density is yet to be established. Here we describe an in vivo biochamber xenograft system in xenograft SCID mice as a model of human MD. Maintenance of MD characteristics was assessed in stromal, epithelial and adipose elements of human mammary tissue propagated in the pseudo-orthotopic mouse mammary environment using histologic and radiographic analyses [15, 16] . The observed preservation of human MD features in the biochamber enables future molecular investigations on the biology of MD.
Method
Accrual of high and low MD regions of the same breast The mammograms of each participant were examined by a breast radiologist and their Birads category noted. Targeted sampling of high and low MD regions of the mastectomy specimen was performed with SenoRx 10 Gauge stereotactic vacuum-assisted biopsies ( Supplementary Fig. 1 ), as previously described [13] . The regions biopsied were away from any potential malignancies or suspicious microcalcifications. Keeping the tissues viable and sterile, these high and low MD biopsies were partitioned for murine biochamber propagation, histological analysis (formalin-fixed, paraffin-embedded and OCT) and for future analysis (snap frozen in liquid nitrogen).
Bio-engineering chambers in SCID mice
To test the stability of human breast MD within mouse xenograft chambers, high and low MD tissue sampled from within the same fresh mastectomy specimen was minced, mixed 1:1 with Matrigel (BD Biosciences, Bedford, MA) and supplemented with FGF-2 (1 lg/ml, Sigma-Aldrich, Sydney, Australia), then implanted into separate silicone biochambers in the right and left groins, respectively, of multiple SCID mice (n = 3-7) and sustained by the mouse epigastric pedicles, as previously described (Supplementary Fig. 1 ) [15, 16] . Material from the murine biochambers was harvested after 6 weeks. At harvest, the resultant tissue from each chamber was examined radiographically and histologically.
Histological analysis
Paraffin-embedded tissue sections (4 lm) were stained with haematoxylin and eosin (H?E). The slides were ; the image of the whole section was used to quantify percentage and absolute areas of epithelial, adipose and stromal tissue components. The perimeter of the biochamber or mastectomy biopsy material was demarcated to determine its total area, then a thresholding mask applied for each of the stromal and glandular components before their respective areas were determined [13, 17] . The adipose area was calculated by subtracting stromal and glandular areas from the total area.
Immunohistochemistry
Human cells were distinguished from murine cells by antihuman mitochondrial antibody (h-mito Ab) (Thermo Scientific Mitochondria Ab-2, Clone MTC02, Cat. #MS-1372-P1)) and Vimentin (V9) (DakoCytomation, Clone V9, Code M0725) staining. These were validated in control experiments containing mouse tissue only as the negative control, and human tissue only as a positive control. Pancytokeratin (CK) (DakoCytomation, Clone MNF116, Code M0821) staining was performed to identify epithelial cells. exponentially stepped transparency sheets was placed on each film to enable standardization of x-ray densitometry in relative densitometry units. Matched pairs of propagated high and low MD biochamber cores, cut to the same thickness (2 mm), were imaged. The faxitron image was digitized and analysed using a densitometer. Image analysis software (JMicroVision v1.2.7) was used to determine the mode of signal intensity for each core, compared to the signal intensity of the calibration strip.
Statistical analysis
High and low MD tissue accrued from the same breast was implanted in matched biochambers of each mouse, thus we performed 'within-individual' analysis to eliminate confounding by external factors. Normality was assessed using the D'Agostino and Pearson Omnibus normality test prior to determining statistical significance. To compare the percentage tissue composition, glandular counts and relative densitometry between high and low MD biochamber tissues, paired t tests were used for parametric data (GraphPad Prism). The percentage tissue composition of the murine biochamber and the original mastectomy biopsy tissues were compared using unpaired t tests. The composition of biochamber tissue elements of high MD tissue originating from women with a BRCA mutation was compared to noncarriers, using unpaired t tests. The p value of significance for rejecting a null hypothesis was 0.05.
Results

Study sample
The study sample comprises paired high and low MD biopsies from fifteen women who underwent prophylactic mastectomy, selected from the Breast Multidisciplinary Meeting. The demographic characteristics of the women are shown in Tables 1 and 2 .
Preservation of histological differential
On H?E staining of the high and low MD biochamber tissue sections, mammary epithelial glandular structures formed by epithelial cells with ductal and lobular architecture were visible within the stromal compartment (Fig. 1) . Morphologically, the glandular structures in both the high and low MD tissue from the biochambers (Fig. 1a,  b ) appeared smaller and less complex than the original mastectomy tissue (Fig. 1c, d ). This contrasted with the parental material, where such smaller and less complex glands were seen preferentially in high MD tissues [13] . The organisation of the stromal and adipose elements was also preserved, reflecting similar histological findings in the original biopsies of high and low MD human tissues (Fig. 1) . The stromal tissues contained viable stromal cells, and collagen that stained with MTB (Fig. 2) . MTB staining revealed increased amount of collagen in high compared to low MD chamber tissues, although in both cases the collagen had a similar distribution adjacent to glandular structures in a circumferential manner (Fig. 2) .
Preservation of glandular and stromal structures of human origin
Pan-cytokeratin and vimentin staining of the biochamber tissues revealed preserved epithelial glandular and stromal structures, respectively, consistent with findings in the original human breast tissue (Figs. 1 and 3a , b) [13] . Vimentin and h-mito Ab staining is human-specific [16] . The appearance of brown-speckled h-mito Ab staining within the cytoplasm of mammary epithelial and stromal cells, and vimentin in stromal cells, of high and low MD biochambers (Fig. 3c, d ), confirms the persistence of human mammary and stromal structures after propagation in the murine biochambers. These human glandular structures demonstrated an orderly ductal and lobular architecture within human stromal tissue.
In one instance, a few smaller rudimentary mouse mammary ducts were noted in adipose tissue near the artery and vein of the murine epigastric pedicle, similar to those seen in previous studies [15] . These did not take up the h-mito Ab stain, confirming their murine origin (Supplementary Fig. 4 (a) ). The majority of adipose cells did not stain with h-mito Ab, but stained with murine-active vimentin antibody, indicating murine origin (Supplementary Fig. 4 (b) ).
The high and low MD biochamber glandular tissue had similar ER expression compared to the original human mastectomy biopsies (Fig. 4a, b) , with no difference between ER staining of high and low MD biochamber tissues (Fig. 4c, d ). ER staining was most prominent in glandular luminal epithelial nuclei of both mastectomy biopsy and biochamber tissues.
Proliferation of glandular and stromal cells within biochambers
Ki67 staining indicated cellular proliferation within both glandular and stromal cells in high and low MD biochamber tissues (Fig. 5c, d ). There was no difference between Ki67 rates of high and low MD biochamber tissues (Fig. 5) . However, the biochamber tissues had increased glandular Ki67 expression compared to the original human mastectomy biopsies (Fig. 5a, b) .
Quantitative analysis of biochamber tissue components
Analysis of matched data for the percentage composition of stroma, fat and glandular tissue in the biochamber and mastectomy tissues each revealed a normal distribution. Paired analysis of tissue component areas in the high and low MD biochamber material with t tests revealed a significant difference in the percentage area of stroma (p = 0.0002) and fat (p = 0.0006), with increased stromal and decreased adipose content in high MD biochamber tissues (Fig. 6a) . No difference was observed in the gland percentage area between high and low MD biochamber tissues (p = 0.4) (Fig. 6a) . When comparing the percentage area composition of the high and low MD biochamber tissue components to the original high and low MD human breast biopsies, there was a similar histological composition (Fig. 6b) ; the high MD human breast biopsies likewise had increased stromal (p = 0.0007), decreased fat (p = 0.002) and no difference in glandular areas (p = 0.7). Quantification of the glands in high and low MD biochamber tissues ( Supplementary Fig. 2 ) did not reveal a significant difference in gland numbers (p = 0.4).
The stromal, adipose and glandular areas of tissue harvested from high MD biochambers that originated from women who carried a BRCA1/2 mutation were compared to the high MD biochamber tissues of non-carriers. There was no difference in the stroma (p = 0.6), adipose (p = 0.7) or gland areas (p = 0.3) between high MD biochamber tissues of these two groups of women (Fig. 7) .
Radiographic analyses of biochamber tissue postpropagation
Faxitron imaging of propagated high and low MD material confirmed that the high MD tissue appeared white on a dark background, and low MD tissue appeared grey on a dark background ( Supplementary Fig. 3) . Qualitatively, the high MD biochamber tissue appeared lighter than the propagated low MD tissue, against the dark background. Quantitative analysis with densitometry and computerized image analysis of signal intensity of high and low MD biochamber tissues from within the same patients (Fig. 8) confirmed that propagated high MD cores had higher relative densitometry compared to low MD cores (p = 0.0004).
Discussion
Conservation of MD histological phenotype and radiographic density of biochamber tissues Using stereotactic methods, we precisely sampled high and low MD regions within the same breast, and described their associated histological features in a previous study [13] . Here we assessed the maintenance of differential MD histology after propagation of high and low MD human tissue in murine biochambers, with correlation to known histological findings in the original breast tissue [13] . Comparing the high MD biochamber tissue histology to that of the original mastectomy biopsies, the high MD mastectomy biopsies similarly had increased stromal and decreased fat areas, suggesting that the MD histological phenotype is conserved in this model. Immunohistochemistry assessment (ER, vimentin, pan-cytokeratin) of high and low MD biochamber tissue also reflected similar findings to that in original mastectomy tissue biopsies.
To quantify the degree of MD in the sub-organ level of human breast core biopsies, we previously described a method of faxitron analysis (using percentage area of high and low MD areas within the biopsy [13] ). We were able to adapt this to the murine biochambers, allowing reproducible and standardised comparisons of the radiographic density of high and low MD biochamber tissues across multiple experiments. The high MD human breast tissue propagated in murine biochambers for 6 weeks maintained an increased radiographic density, and the degree of this increased density was measurable as multiples of a standardised unit (relative densitometry unit).
Preservation of human mammary structures and stromal microenvironment
We confirmed the maintenance of human mammary ducts and lobules adjacent to human stromal cells, stained with h-mito Ab and Vimentin, within the high and low MD biochamber environment. The occasional mouse mammary gland was seen to invade adipose tissue near the neurovascular pedicle and persist as rudimentary glands.
Nuclear staining with Ki67 antibody demonstrated that proliferation of stromal and human mammary epithelial cells occurred in the biochambers over 6 weeks. This is important given the role of epithelial-stromal interactions, where signals between epithelial cells, fibroblasts and extracellularmatrix in the breast microenvironment can give rise to enhanced cellular proliferation and invasion, leading to development and progression of breast cancer [18] [19] [20] [21] [22] . The exact contribution and interplay of the cells and processes that result in the increased malignancy risk associated with MD is unclear, thus a model of MD that maintains these human compartments in a dynamic manner is crucial.
In studies of human breast epithelial cell lines grafted into mouse models, the mice were often supplemented with subcutaneous steroid hormone pellets, because of the lower levels of serum oestradiol in mice compared to humans. During our initial biochamber experiments, we observed that the de novo murine serum oestradiol level was sufficient to maintain glandular structures of human origin within the biochambers for 6 weeks, without addition of hormone pellets. We also observed similar levels of ER staining in the glandular epithelium of parental mastectomy and biochamber tissues, suggesting preservation of the ER phenotype. Moreover, the matched-pairs study design allows for elimination of any potential confounding from lower murine serum oestradiol systemically.
Small and less complex glandular structures were seen in both low and high MD biochambers compared to the parental mastectomy biopsies. A potential explanation is that during the biochamber propagation process, only the stem-like mammary cell population survived to form small glands [23] . Ki67 expression was greater in biochamber tissues compared to the original mastectomy tissue, suggesting that high and low MD glandular tissues may respond to stimuli within the biochamber microenvironment.
Increased stromal and collagen content
Paired analysis confirmed a greater proportion of dense stromal tissue and collagen in high compared to low MD chamber tissue. This increased stromal content has been observed in several studies examining the histology of high MD samples in women [13, 24] , and provides further evidence for the validity of the biochamber model. In a mouse model examining the increased breast cancer risk during postpartum involution, Lyons et al. [25] demonstrated that radial alignment of collagen fibres and increased COX-2 expression may drive the formation of ductal carcinoma in situ. Provenzano et al. [20] have proposed that increased matrix stiffness could partly explain the increased cancer risk in high MD. Transgenic mice engineered with collagen that resisted normal enzymatic clearance led to premalignant changes, and when combined with a mammary oncogene, caused increased tumour formation, with more invasive and metastatic potential [26] . The biochamber model provides an opportunity to test the role of collagen and extracellular matrix in subsequent studies.
Few existing models of MD
Despite large epidemiological studies demonstrating that high MD is a significant risk factor for breast cancer [3, [5] [6] [7] [8] , the mechanisms of how high MD promotes breast carcinogenesis remains unclear. A robust animal model for studying MD in vivo may ultimately clarify this. Hariri et al. [14] investigated the radiographic density and histology of murine MFPs deficient in epithelial structure, and containing hyperplastic or malignant epithelium. Digitized images of MFP whole mounts, with epithelial mass and breast density measurement using computer-aided thresholding has been described [27] .
As such, few animal models of murine mammary density exist to date, due to various challenges, including the lack of standardised measurement of mammary gland radiographic density, and difficulty in maintaining MD over a sufficient duration to enable tumorigenesis. Moreover, the composition of the rodent mammary gland is quite different from the human, thus may not accurately reflect the alterations in human MD and its implications. The murine gland contains small epithelial structures within a larger amount of adipose tissue, and less stromal tissue, compared to the human mammary gland.
Strengths and limitations of the model
Currently, there is no orthotopic xenograft model that can recapitulate human MD, with the potential for manipulation of its microenvironment to investigate MD and its role in oncogenesis. Prior to our study, quantitative histological and radiographic analyses of high and low MD human mammary tissues in an animal model have not been reported. This murine model is the first to demonstrate maintenance of human mammary glandular structures and stromal tissue within high and low MD chamber tissues for the purpose of modelling MD and its associated risk. Ki67 staining of the biochamber tissues indicates that cellular proliferation can occur in human glandular and stromal structures during the 6 weeks. If the high and low MD tissue of human origin responds in a dynamic manner to changes in the biochamber microenvironment, it may be amenable to interventional studies of endocrine, drug and gene manipulation. The driving molecular variables around lifestyle milestones in a woman that can modulate MD, such as pregnancy and postpartum mammary involution, are under investigation in the biochamber model.
One potential issue is that the high and low MD human tissues implanted in the murine biochambers were taken from a high-risk population. In our study sample of 15 women, seven women were BRCA1/2 mutation carriers. Since the malignancy risk associated with MD is independent of BRCA mutation status [28, 29] , we expect no observable difference in the MD phenotype of the chamber tissue between the two groups. In this study, there was no difference in the stromal, adipose or glandular areas of biochamber tissues originating from women who were gene carriers and those who were not. This is supported by our previous finding that there was no difference in the MD histological phenotype of human breast core biopsies by BRCA1/2 mutation status [13] .
Steroid hormones such as oestrogen and progesterone hormone replacement therapy (HRT) can increase MD directly [30, 31] . The majority of the women in our study were pre-menopausal: in the sample of 15 women, only one was post-menopausal. Thus, we would expect minimal effect due to age-related involution or HRT usage.
Finally, in our study design, we performed selective biopsies of matched high and low MD tissue from within the same breast of each woman, then implanted these into paired chambers in right and left groins of host mice. This matched-pairs design enables comparison of the high and low MD chamber tissue without the effect of potential confounders, including the BRCA mutation status, menopausal status and parity of the women, as well as processrelated factors in the murine model.
Conclusion
Immunohistochemical staining confirms the persistence of human glandular and stromal elements in high and low MD human mammary tissue propagated within murine biochambers, while faxitron imaging demonstrates preservation of the MD differential within the model. Quantitative analyses reveal increased stromal and decreased adipose area in high compared to low MD biochamber tissues, reflecting the findings in the original mastectomy tissue [13] . Our study provides a validated platform for future studies into the biomolecular basis of MD as a risk factor for breast cancer. The correlation of the effects of modifying factors on PMD, and the changes brought about by such agents on breast tissue histology, proliferative state and stroma, is an important area for further research. Our experimental model may prove a useful tool to further elucidate the role of hormonal factors and mitogens, by assessing dynamic changes in the MD phenotype.
